Home > News > Phoenix firm to provide $40M in VC funds
June 20th, 2005
Phoenix firm to provide $40M in VC funds
A new Phoenix bioscience firm that provides scientific expertise to venture capital funds is in the process of forming its own $40 million pool to help industry startups get their products to market.
Scientists who give their input on technology, such as proteomics and nano-biotechnologies, also would have the opportunity to participate in the VC fund they are helping, said Neff, who serves as chief executive of Bioscience Intelligence Advisors.
Bioscience Intelligence Advisors
Harris & Harris Group Notes the Receipt of Proceeds From the Sale of Molecular Imprints' Semiconductor Business to Canon April 22nd, 2014
Harris & Harris Group Continues Its Blog Series to Highlight Most Impactful Portfolio Companies With Champions Oncology, Inc. April 17th, 2014
Nanometrics to Announce First Quarter Financial Results on April 29, 2014 April 9th, 2014
Harris & Harris Group Notes Mersana's Collaboration Agreement With Subsidiary of Takeda Pharmaceutical Co. April 8th, 2014
Making graphene work for real-world devices: Fundamental research in phonon scattering helps researchers design graphene materials for applications April 24th, 2014
Return on investment for kit and promotion materials April 24th, 2014
Protecting olive oil from counterfeiters April 24th, 2014
High-Performance, Low-Cost Ultracapacitors Built with Graphene and Carbon Nanotubes: Future devices based on technology could bridge gap between batteries and conventional capacitors in portable electronics and hybrid electric vehicles April 23rd, 2014